Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2α as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Science (New York, N.Y.)|September 29, 2022
Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell functionGiulia Notarangelo, Jessica B Spinelli, Elizabeth M Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in GlioblastomaJ Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.
Nature|June 21, 2023
B-cell-specific checkpoint molecules that regulate anti-tumour immunityLloyd Bod, Yoon-Chul Kye, Jingwen Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse modelsMeenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|September 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral controlSarah A Weiss, Amy Y Huang, Megan E Fung, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Pageof 42